Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Regenerative Medicine Market to Reach a Valuation of USD 127.86 Billion by 2032, Backed by Advancement in Cell Therapy, States Extrapolate


News provided by

Extrapolate

15 May, 2023, 14:32 GMT

Share this article

Share toX

Share this article

Share toX

DUBAI, UAE, May 15, 2023 /PRNewswire/ -- According to the latest research report published by Extrapolate, the global Regenerative Medicine Market is poised to experience substantial growth and accrue a market size of USD 127.86 billion by 2032, recording a CAGR of 17% between 2023 and 2032. This is a significant increase from the base market size of USD 31.05 Billion in 2022, owing to the increasing utilization of stem cell technology.

Several advances in biological therapies have shifted the preference from traditional treatment methods toward personalized medicinal strategies. This has created significant opportunities for regenerative medicine industry participants involved in developing biological therapeutics.

Get a Sample PDF of the Report: https://www.extrapolate.com/sample/healthcare-medical-devices-biotechnology/regenerative-medicine-market/87510

Trending Now: PHC Group Presence in Regenerative Medicine Expands, Epredia and Aiforia Join RegenMed Hub Innovation Accelerator

PHC Group, a global healthcare company and leader in diagnostics and life sciences will join the Regenerate OR Innovation Accelerator to expand its presence in regenerative medicine. The RegenMed Development Organization (ReMDO) and the Wake Forest Institute for Regenerative Medicine (WFIRM), two organizations in the Innovation Quarter that are accelerating the discovery and translation of regenerative medicine therapies, announced on January 18th, 2023, at a special event.

The companies work together to provide slide imaging and AI-based solutions that enable researchers to explore and extract information beyond the scope of human visual perception. Diagnostic microscopic imaging and artificial intelligence (AI) have created a link between drug discovery, translational, and clinical research programs aiming to better understand disease states.

Growing Approval of GMP Certification to Augment Growth Prospects for Cell Therapies

The cell therapies segment accounted for the most significant global market share and is anticipated to continue its dominance during the forecast period. The increasing GMP certification approvals for cell therapy production facilities are the major factor driving the growth of the regenerative medicine market segment.

Unlock key industry insights with our research report. For More Information, Enquire Now! https://www.extrapolate.com/enquire/healthcare-medical-devices-biotechnology/regenerative-medicine-market/87510

Musculoskeletal Segment to Experience Significant Growth Due to Increasing Frequency of Genetic Disorders

The musculoskeletal segment was the leading contributor in 2022 and is predicted to continue its dominance during the projection period, owing to an increase in the frequency of genetic disorders. Furthermore, the growing knowledge of musculoskeletal regeneration, along with the prevalence of orthopedic disorders, has contributed to the growth of the segment. Furthermore, research and development of regenerative and advanced cell therapies for musculoskeletal diseases have received significant funding in recent years, increasing growth opportunities.

Surging Stem Cell Technology Adoption Globally to Fuel Market Growth

The emergence of stem cell technologies has given rise to a new market platform for tissue engineering and regenerative medicine. Unexplored areas of stem cell technologies, such as umbilical cord blood stem cells, offer lucrative opportunities to the tissue engineering and regeneration industry. Every organ regeneration and tissue engineering procedure demands the use of proliferative and differentiated cells. In addition, cord blood stem cells are undetermined cells derived from allogenic stem cells and autologous stem cells.

Moreover, stem cell research has received significant attention and has been extensively researched in the field of medicine. ExCellThera Inc. and Ossium Health recently announced a collaboration to evaluate and advance opportunities to use adult stem cells from deceased donors from Ossium Health's world-first bone marrow bank in conjunction with ExCellThera's ECT-001 cell expansion and rejuvenation technology in April 2021. Such developments are expected to boost the regenerative medicine market growth.

Purchase This Comprehensive Research Report for Valuable Market Insights: https://www.extrapolate.com/complete-checkout-buy/87510

North America to Aid Market Growth Due to Supportive Private and Government Funding

North America dominated the regenerative medicine market share in 2022 and is projected to continue its dominance in the near future. The availability of government and private funding and the presence of advanced technology frameworks to support development is attributed to the high market growth. In the United States, there is an increasing prevalence of diseases such as cancer and diabetes that can now be cured by various stem cell therapies. According to the Heart Disease & Stroke Statistical Fact Sheet 2020, congenital heart defects are expected to affect at least 40,000 infants in the United States each year.

Asia Pacific to Grow at the Fastest Rate Amid Accelerated Healthcare Industry Development

Asia Pacific is expected to grow at the fastest rate in the upcoming years due to the rapid adoption of cell-based approaches in healthcare and the region's growing geriatric population. Government initiatives to advance technology and increase disposable income are creating growth opportunities in the region. According to a BioSpectrum article published in November 2021, 8.5 million people in Asia suffer from chronic diseases such as diabetes, cancer, and respiratory conditions. The rising prevalence of diseases presents a potential opportunity for regenerative medicine market growth throughout the region.

For more information on the report, visit: https://www.extrapolate.com/healthcare-medical-devices-biotechnology/regenerative-medicine-market/87510

Competitive Landscape

The global market for regenerative medicine is fiercely competitive. Small and large businesses are focusing on collaboration to create tissue models for research and therapeutic purposes. As a result, companies are investing heavily in novel technologies, ultimately driving the market's growth.

Prominent players in the market include:

  • 3M
  • Amgen Inc.
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • Hoffmann-La Roche Ltd
  • Integra LifeSciences
  • Merck KGaA
  • Meso Numismatics, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Verita Neuro Pte Ltd

Key Points from TOC:

Chapter 1. Executive Summary

Chapter 2. Research Methodology

Chapter 3. Market Outlook

Chapter 4. COVID-19 Impact on Global Regenerative Medicine Market

Chapter 5. Global Regenerative Medicine Market Overview, By Product Type, 2018 - 2032 (USD Million)

Chapter 6. Global Regenerative Medicine Market Overview, By Material, 2018 - 2032 (USD Million)

Chapter 7. Global Regenerative Medicine Market Overview, By Application, 2018 - 2032 (USD Million)

Chapter 8. Global Regenerative Medicine Market Overview, By End User, 2018 - 2032 (USD Million)

Chapter 9. Global Regenerative Medicine Market Overview, By Geography, 2018 - 2032 (USD Million)

Chapter 10. North America Regenerative Medicine Market Overview, By Countries, 2018 - 2032 (USD Million)

Continued…….

About Us:

Extrapolate is a Global Market Research, Advisory, and Consulting firm that works closely with Industry experts from various industries to bring the latest and most accurate research reports.

In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets - not merely respond to them. Extrapolate helps clients develop market perspectives that drive success.

Contact Us

Extrapolate
Phone: (+1) 888 328 2189
E-mail: talk@extrapolate.com
Website: https://www.extrapolate.com
Blog: https://www.extrapolate.com/blog
Follow Us: LinkedIn | Facebook | Twitter

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.